Are HIV positive patients resistant to statin therapy?
<p>Abstract</p> <p>Background</p> <p>Patients with HIV are subject to development of HIV metabolic syndrome characterized by dyslipidemia, lipodystrophy and insulin resistance secondary to highly active antiretroviral therapy (HAART). Rosuvastatin is a highly potent HMG...
Main Authors: | Bennett Matthew T, Johns Kevin W, Bondy Gregory P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/6/1/27 |
Similar Items
-
Statins and Insulin Resistance
by: GM Sanvee, et al.
Published: (2020-05-01) -
Statin therapy compliance
by: N. Sh. Zagidullin, et al.
Published: (2008-02-01) -
Statin Therapy and the Assessment of Hepatoprotection in Patients with Dyslipidaemia
by: Marinela Beznă, et al.
Published: (2023-04-01) -
Myopathy associated with statin therapy.
by: Hilton-Jones, D
Published: (2008) -
Statins in COVID-19 Therapy
by: Justyna Olszewska-Parasiewicz, et al.
Published: (2021-06-01)